High flow nasal oxygen as a "second-line" therapy for COVID-19 patients intolerant to noninvasive ventilation. A retrospective cohort study.
Federico LionelloGabriella GuarnieriGiovanna ArcaroAndrea VianelloPublished in: Health science reports (2023)